https://commons.ru.ac.za/vital/access/manager/Index ${session.getAttribute("locale")} 5 The use of experimental design in the development of an HPLC–ECD method for the analysis of captopril https://commons.ru.ac.za/vital/access/manager/Repository/vital:44163 Tue 14 May 2024 11:59:47 SAST ]]> Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers https://commons.ru.ac.za/vital/access/manager/Repository/vital:44156 Tue 14 May 2024 11:59:25 SAST ]]> Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex https://commons.ru.ac.za/vital/access/manager/Repository/vital:44190 Tue 14 May 2024 11:59:01 SAST ]]> Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain https://commons.ru.ac.za/vital/access/manager/Repository/vital:44160 Tue 14 May 2024 11:58:13 SAST ]]> Drug transport mechanisms from carbopol/eudragit verapamil sustained-release tablets https://commons.ru.ac.za/vital/access/manager/Repository/vital:44273 Tue 14 May 2024 11:03:40 SAST ]]>